Use este identificador para citar ou linkar para este item:
https://www.arca.fiocruz.br/handle/icict/60913
Tipo de documento
Trabalhos apresentados em eventosDireito Autoral
Acesso aberto
Coleções
Metadata
Mostrar registro completo
PROCESS MAPPING TO SUPPORT DELIVERY OF LONG-ACTING INJECTABLE CABOTEGRAVIR FOR HIV PRE-EXPOSURE PROPHYLAXIS WITHIN PUBLIC HEALTH SYSTEMS: THE IMPREP CAB BRASIL STUDY
Título alternativo
Mapeamento de processos para apoiar a entrega de cabotegravir injetável de ação prolongada para profilaxia de pré-exposição ao HIV nos sistemas de saúde pública: o estudo IMPREP CAB BRASILAutor(es)
Afiliação
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
University of Washington. Schools of Medicine and Public Health. Department of Global Health. Seattle, USA.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil.
Ministério da Saúde. Brasília, DF, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil.
University of Washington. Schools of Medicine and Public Health. Department of Global Health. Seattle, USA.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil.
Ministério da Saúde. Brasília, DF, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil.
Resumo em Inglês
Background: Although long-acting injectable cabotegravir (CAB-LA) PrEP has proven efficacious for HIV prevention in clinical trials, additional research is needed to evaluate effective implementation in real world settings. The ImPrEP CAB-Brasil study will evaluate the feasibility, acceptability, and effectiveness of delivering same-day CAB-LA for HIV prevention in six PrEP public health clinics. Process maps are a diagrammatic representation of organizational processes and are widely used in healthcare quality management and improvement; however, literature is sparse in describing their use to incorporate clinical innovations into routine practice. We used process mapping to operationalize plans for integrating injectable PrEP with existing oral PrEP services. Description: We used a four-step approach to process mapping: preparation, mapping and analyzing, customization and co-creation, and validation. We first conducted individual interviews with study sites health professionals. Based on these interviews, we created initial process maps, customized for each site. Then, we held online meetings with health professionals and peer educators from each site who were encouraged to provide honest and constructive opinions during the discussions, especially about possible barriers/risks to planned models of service delivery. Finally, we asked the same personnel to validate revised process maps and to ensure there were no missing steps. We applied Business Process Management discipline using Bigazi Modeler Software, version 4.0. Lessons Learned: We created three process maps for each site to describe the initial CAB-LA PrEP user visit, follow-up visits and laboratory flow (18 maps total). Main challenge identified during the process was the duration of visits due to great number of laboratory and HIV counseling steps for the same-day PrEP delivery. Solutions proposed included (1) use of point-of-care HIV rapid tests instead of laboratory tests, which sites expressed the need for additional training to perform it; (2) more staff performing counseling. Two sites identified the need to expanding clinic hours for the project to better serve the study population, also contributing to oral PrEP scale-up. Conclusions: Process modeling was a powerful tool for planning an injectable PrEP implementation study within Brazilian Public Health System. Continuous monitoring of the implementation of mapped processes will help identify further barriers and solutions to CAB-LA PrEP delivery.
Compartilhar